Northway Biotech Launches Full-Service Viral Clearance Studies, Delivering Results Faster Than Industry Standards
With six newly established, identical BSL-2 laboratories now operational, biologics CDMO Northway Biotech can conduct VCS programs for up to six clients simultaneously, significantly alleviating current market bottlenecks
VILNIUS, LT / ACCESS Newswire / May 5, 2025 / Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), today announced the expansion of its protein-based and gene therapy service offerings with the addition of Viral Clearance Studies (VCS) capabilities. This strategic growth follows the opening of Northway Biotech's new Gene Therapy Center with dedicated cGMP facilities for virus-related projects.
With six newly established, identical BSL-2 laboratories now operational, Northway Biotech can conduct VCS programs for up to six clients simultaneously, significantly alleviating current market bottlenecks. Additionally, the company has expanded its capabilities to perform GMP-compliant manufacturing and testing under BSL-3 conditions, further strengthening its service offering across gene therapy and broader biologics development.
Viral Clearance Studies are now offered both as part of Northway Biotech's integrated CDMO programs and as a standalone service. This flexibility allows external clients to access VCS expertise independently, without requiring a manufacturing agreement.
Accelerated Delivery Timelines - Over One Month Faster Than Industry
Leveraging expanded infrastructure and integrated analytical capabilities, Northway Biotech is positioned to deliver Viral Clearance Studies substantially faster than the current industry standard. Comprehensive studies, assessing viral removal and inactivation, can now be completed with final regulatory-compliant reporting in under 10 weeks from initiation of project design when two model viruses are employed, and within 12 weeks when four model viruses are used.
"Our expansion into Viral Clearance Studies is a natural extension of our CDMO services, enabling us to manage these critical studies in-house and significantly reduce project timelines for our clients," said Prof. Vladas Algirdas Bumelis, CEO of Northway Biotech. "By investing in state-of-the-art BSL-2 and BSL-3 facilities, expanding technical capabilities, and further strengthening our scientific teams, we are uniquely positioned to deliver high-quality VCS data faster - a key advantage for clients advancing through clinical development and regulatory approval."
For more information on Northway Biotech's Viral Clearance Study processes, service offerings, and delivery timelines, please complete the contact form to connect with the Northway Biotech team.
About Northway Biotech - https://www.northwaybiotech.com
Northway Biotech is a leading contract development and manufacturing organization (CDMO) supporting customers worldwide. Its highly experienced and professional team executes projects at every stage, from cell line construction and process development to cGMP manufacturing of biopharmaceutical products. The company's extensive expertise and vertically integrated service offering enables rapid execution of multiple projects from its state-of-the-art GMP facilities while ensuring full process and product compliance at all stages of research, development, and commercial manufacturing. Northway Biotech is a privately owned company founded in 2004 and operates locations in Vilnius, Lithuania; London, United Kingdom; and Waltham, MA, USA.
Media & Business Contact:
Prof. Vladas Algirdas Bumelis
CEO and Chairman of the Board
Northway Biotech
vladas.bumelis@northwaybiotech.com
Contact Information
Vladas Bumelis
CEO and Chairman of the Board
vladas.bumelis@northwaybiotech.com
SOURCE: Northway Biotech
View the original press release on ACCESS Newswire
Northway Biotech
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Camino Announces High-Grade Channel Results of 7 Meters @ 4.3% Copper, 25.5 ppm Silver and 18 meters @ 1.57 % Copper and 11.35 ppm Silver at Los Chapitos in Peru17.6.2025 12:00:00 CEST | Press release
VANCOUVER, BC / ACCESS Newswire / June 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ("Camino" or the "Company") is pleased to announce high‐grade copper channel results from the Katty prospect located in the Diva Trend, one of several prospective targets at the Company's Los Chapitos Copper Project ("Los Chapitos" or the "Project") in Peru. A total of 12 excavated channels were completed at the prospect and all channels contained significant high-grade intercepts of copper with associated silver (Table 1). Los Chapitos is Camino's second copper project with partner Nittetsu Mining Co, Ltd. ("Nittetsu"), which can earn a 35% interest in Los Chapitos once it completes a total investment of CDN$10 Million (see news release dated June 14, 2023). Rio Tinto, a major copper producer, recently staked claims adjacent to Los Chapitos (see news release dated May 17, 2024). Camino is also advancing its mine development project, the Puquios Copper Project, with Nittetsu Mining
The 12th GLA Global Logistics Conference: A New Chapter in International Logistics Cooperation17.6.2025 05:50:00 CEST | Press release
DUBAI, AE / ACCESS Newswire / June 16, 2025 / From May 15 to 18, 2025, the 12th GLA Global Logistics Conference was held at the Grand Hyatt Dubai, shaping the future of the international logistics landscape. Organized by the Global Logistics Enterprises Federation (GLEF) and the GLA Global Logistics Alliance, the conference gathered nearly 2,000 professionals, including logistics experts, senior executives and government officials from over 130 countries and regions. This year's edition reinforced GLA's position as a central hub for strategic networking, innovation and global trade cooperation. Group Photo of the 12th GLA Global Logistics Conference Under the theme "Peaceful Prosperity · Digital Innovation · Trustworthy Cooperation," the conference reflected the logistics sector's collective ambition to respond to today's challenges, ranging from geopolitical disruptions and supply chain volatility to technological advancement and environmental demands. The Opening Ceremony of the 12th
Corsair Signs Strategic Partnership with Kera Energy for Global Distribution of Pyrolysis Oil16.6.2025 09:10:00 CEST | Press release
New partnership expands global access to Corsair's recycled plastic oil across Europe, Asia, and the Americas. AMSTERDAM, NETHERLANDS / ACCESS Newswire / June 16, 2025 / Plastic waste recycling company Corsair Group International Holding BV (CORSAIR) is proud to announce a new strategic partnership with KERA Energy AG, a Swiss-based leader in sustainable industrial value chains. Under the agreement, CORSAIR will supply advanced pyrolysis oil to KERA Energy, which will distribute the Plastic Pyrolysis Oil (PPO) across key markets in Europe, Asia, and the Americas. This collaboration marks another important step in CORSAIR's mission to scale up sustainable advanced recycling of plastic waste. The agreement with KERA Energy signals growing international demand for CORSAIR's high-quality pyrolysis oil derived from everyday household plastic waste. "We are very pleased to partner with KERA Energy, a company that shares our vision of a cleaner, circular economy," said Jussi Veikko Saloranta,
GA-ASI Announces New PELE Small UAS for International Customers16.6.2025 06:00:00 CEST | Press release
Small, Uncrewed Launched Effect Delivers Multi-Mission Capability SAN DIEGO, CA / ACCESS Newswire / June 16, 2025 / General Atomics Aeronautical Systems, Inc. (GA-ASI), the world leader in unmanned aircraft from the iconic Predator® to the YFQ-42A Collaborative Combat Aircraft, has unveiled a new small uncrewed launched effect with widespread multi-mission capabilities for the global aerospace and defense market. Inspired by Pele, the Hawaiian goddess of powerful natural forces in the Pacific, the Precision Exportable Launched Effect - PELE - is a small, attrition-tolerant, propeller-driven unmanned aircraft designed to extend the sensing and other capabilities of a mothership aircraft and its user service. PELE is a semi-autonomous unmanned aircraft system (UAS) with an 11-foot wingspan and 16-horsepower engine that extends user reach within challenging environments with potent effects. PELE also could be launched from the ground. The new PELE is optimized for use on the MQ-9B SkyGuar
GA-ASI Adds Saab Airborne Early Warning Capability to MQ-9B16.6.2025 06:00:00 CEST | Press release
New Capability Will Transform Airborne Early Warning Access and Affordability for MQ-9B Customers SAN DIEGO, CA / ACCESS Newswire / June 16, 2025 / General Atomics Aeronautical Systems, Inc. (GA-ASI) is partnering with Saab to develop Airborne Early Warning and Control (AEW&C) capability for its line of MQ-9B Remotely Piloted Aircraft, which includes the SkyGuardian® and SeaGuardian® models, the United Kingdom's Protector, and the new MQ-9B STOL (Short Takeoff and Landing) model currently in development. GA-ASI plans to fly AEW on MQ-9B in 2026. "High and low-tech air threats both pose major challenges to global air forces," said GA-ASI President David R. Alexander. "We're developing an affordable AEW solution in cooperation with Saab, the leading provider of AEW&C systems, that will transform our customers' operations against both sophisticated cruise missiles and simple but dangerous drone swarms. We're also making AEW capability possible in areas it doesn't exist today, such as from
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom